Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy C Andrews

Showing results (31-40 of 97) with videos related to

Pageof 10
Sort By:
The New England Journal of Medicine|July 15, 2005
Case records of the Massachusetts General Hospital. Case 21-2005. A four-week-old male infant with jaundice and thrombocytopeniaNancy C Andrews, Sudha Anupindi, Kamran Badizadegan
Blood|July 26, 2003
Transferrin receptor 1 is differentially required in lymphocyte developmentRenee M Ned, Wojciech Swat, Nancy C Andrews
Physiology (Bethesda, Md.)|March 28, 2006
The ins and outs of iron homeostasisAdriana Donovan, Cindy N Roy, Nancy C Andrews
Pediatrics|March 10, 2025
The Urgent Need for More Federal Funding for Pediatric Firearm Injury Prevention ResearchLois K Lee, Alex Butler, Nancy C Andrews
Blood|September 15, 2010
Hepcidin induction by transgenic overexpression of Hfe does not require the Hfe cytoplasmic tail, but does require hemojuvelinPaul J Schmidt, Nancy C Andrews, Mark D Fleming
Blood|December 6, 2003
Hepcidin, a candidate modifier of the hemochromatosis phenotype in miceGaël Nicolas, Nancy C Andrews, Axel Kahn, et al.
Pediatric Research|February 22, 2003
2002 E. Mead Johnson Award for Research in Pediatrics Lecture: the molecular biology of the anemia of chronic disease: a hypothesisCindy N Roy, David A Weinstein, Nancy C Andrews
Blood|March 1, 2011
Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in miceKarin E Finberg, Rebecca L Whittlesey, Nancy C Andrews
Blood|October 20, 2010
Transferrin is a major determinant of hepcidin expression in hypotransferrinemic miceThomas B Bartnikas, Nancy C Andrews, Mark D Fleming
Cell|April 28, 2004
Balancing acts: molecular control of mammalian iron metabolismMatthias W Hentze, Martina U Muckenthaler, Nancy C Andrews
Pageof 10

Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
The New England Journal of Medicine|July 15, 2005
Case records of the Massachusetts General Hospital. Case 21-2005. A four-week-old male infant with jaundice and thrombocytopeniaNancy C Andrews, Sudha Anupindi, Kamran Badizadegan
Blood|July 26, 2003
Transferrin receptor 1 is differentially required in lymphocyte developmentRenee M Ned, Wojciech Swat, Nancy C Andrews
Physiology (Bethesda, Md.)|March 28, 2006
The ins and outs of iron homeostasisAdriana Donovan, Cindy N Roy, Nancy C Andrews
Pediatrics|March 10, 2025
The Urgent Need for More Federal Funding for Pediatric Firearm Injury Prevention ResearchLois K Lee, Alex Butler, Nancy C Andrews
Blood|September 15, 2010
Hepcidin induction by transgenic overexpression of Hfe does not require the Hfe cytoplasmic tail, but does require hemojuvelinPaul J Schmidt, Nancy C Andrews, Mark D Fleming
Blood|December 6, 2003
Hepcidin, a candidate modifier of the hemochromatosis phenotype in miceGaël Nicolas, Nancy C Andrews, Axel Kahn, et al.
Pediatric Research|February 22, 2003
2002 E. Mead Johnson Award for Research in Pediatrics Lecture: the molecular biology of the anemia of chronic disease: a hypothesisCindy N Roy, David A Weinstein, Nancy C Andrews
Blood|March 1, 2011
Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in miceKarin E Finberg, Rebecca L Whittlesey, Nancy C Andrews
Blood|October 20, 2010
Transferrin is a major determinant of hepcidin expression in hypotransferrinemic miceThomas B Bartnikas, Nancy C Andrews, Mark D Fleming
Cell|April 28, 2004
Balancing acts: molecular control of mammalian iron metabolismMatthias W Hentze, Martina U Muckenthaler, Nancy C Andrews
Pageof 10